Short answer · Medically reviewed summary · Last updated: 2026-04-06
Myofascial Pain Syndrome (MPS) is a highly prevalent chronic pain condition, with some clinical estimates suggesting it affects up to 85% of patients who seek treatment at specialized pain management clinics, though exact population-wide prevalence remains difficult to quantify. Prevalence and Classification Unlike many conditions mapped on DiseaseMaps.org, Myofascial Pain Syndrome is not classified as a "rare" disease; rather, it is considered a common, albeit frequently underdiagnosed, musculoskeletal condition. Because it is often secondary to other issues or misidentified as fibromyalgia, there is no definitive global incidence rate.
What is the prevalence of Myofascial Pain Syndrome?
Prevalence of Myofascial Pain Syndrome: how many people are affected worldwide, differences by sex and region, with sources.
Myofascial Pain Syndrome (MPS) is a highly prevalent chronic pain condition, with some clinical estimates suggesting it affects up to 85% of patients who seek treatment at specialized pain management clinics, though exact population-wide prevalence remains difficult to quantify.
Prevalence and Classification
Unlike many conditions mapped on DiseaseMaps.org, Myofascial Pain Syndrome is not classified as a "rare" disease; rather, it is considered a common, albeit frequently underdiagnosed, musculoskeletal condition. Because it is often secondary to other issues or misidentified as fibromyalgia, there is no definitive global incidence rate. Current literature indicates that while MPS is ubiquitous in clinical settings, it is rarely tracked in general population health registries.
Demographics and Onset
Myofascial Pain Syndrome affects both males and females, though some studies suggest a higher prevalence in women, particularly those between the ages of 30 and 60. While it is most commonly diagnosed in middle-aged adults due to cumulative physical strain, it can affect individuals of any age, including children and adolescents, typically following repetitive microtrauma or postural stress. There are no significant ethnic or geographic variations in the occurrence of Myofascial Pain Syndrome, as it is largely linked to mechanical and lifestyle factors.
The Challenge of Data
The primary barrier to accurate prevalence data for Myofascial Pain Syndrome is the lack of standardized diagnostic criteria, leading to significant misdiagnosis. Many patients with trigger points are incorrectly labeled as having generalized fibromyalgia or chronic fatigue. Our DiseaseMaps.org community, which currently includes 110 members, provides a vital real-world perspective that clinical trials often miss. These patient-reported experiences highlight that Myofascial Pain Syndrome is often a chronic, life-altering condition that requires multidisciplinary management, regardless of its status as a "common" rather than "rare" disease.
Medical Disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.
References
- NIH Genetic and Rare Diseases Information Center (GARD)
- Orphanet: The portal for rare diseases and orphan drugs
- National Library of Medicine (PubMed): Systematic reviews on myofascial trigger points
